Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Diabetes. Jul 15, 2024; 15(7): 1562-1588
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1562
Table 1 Databases and platform addresses
Table 2 Active ingredients of the Astragalus-Coptis drug pair
TCM
Serial number
MOL ID
Ingredient
OB (%)
DL
Astragalus membranaceusHQ1MOL0003799,10-dimethoxypterocarpan-3-O-β-D-glucoside36.740.92
HQ2MOL000387Bifendate31.100.67
HQ3MOL0004421,7-Dihydroxy-3,9-dimethoxy pterocarpene39.050.48
HQ4MOL0003713,9-di-O-methylnissolin53.740.48
HQ5MOL000380(6aR,11aR)-9,10-dimethoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-ol64.260.42
HQ6MOL000354Isorhamnetin49.600.31
HQ7MOL0003787-O-methylisomucronulatol74.690.30
HQ8MOL000398Isoflavanone109.990.03
HQ9MOL000239Jaranol50.830.29
HQ10MOL000098Quercetin46.430.28
HQ11MOL000438(3R)-3-(2-hydroxy-3,4-dimethoxyphenyl)chroman-7-ol67.670.26
HQ12MOL000417Calycosin47.750.24
HQ13MOL000422Kaempferol41.880.24
HQ14MOL000392Formononetin69.670.21
Coptis chinensis FranchHL1MOL002903(R)-Canadine55.370.77
HL2MOL001454Berberine36.860.78
HL3MOL002894Berberrubine35.740.73
HL4MOL002904Berlambine36.680.82
HL5MOL001458Coptisine30.670.86
HL6MOL002907Corchoroside A_qt104.950.78
HL7MOL002897Epiberberine43.090.78
HL8MOL000622Magnograndiolide63.710.19
HL9MOL008647Moupinamide86.710.26
HL10MOL013352Obacunone43.290.77
HL11MOL000785Palmatine64.600.65
HL12MOL000098Quercetin46.430.28
HL13MOL002668Worenine45.830.87
Table 3 Information on the differential gene expression analysis identified from the Gene Expression Omnibus dataset
Gene symbol
Protein name
Log2FC
P value
Change
PLCE1Phospholipase C epsilon 13.9804210.00000765Upregulated
CLIC5Chloride intracellular channel 54.3809690.00001522Upregulated
PTPROProtein tyrosine phosphatase receptor type O3.9222490.00001810Upregulated
HSPA12AHeat shock protein family A (Hsp70) member 12A4.1941410.00001836Upregulated
AIF1Allograft inflammatory Factor 13.6162730.00002007Upregulated
GMDSGDP-mannose 4,6-dehydratase3.9002180.00002555Upregulated
SEMA5ASemaphorin 5A3.9568680.00002673Upregulated
CEP152Centrosomal protein 1524.0043390.00002683Downregulated
FOXC1Forkhead Box C13.5057150.00003095Upregulated
MMEMembrane metalloendopeptidase3.8379580.00003666Upregulated
FGF1Fibroblast growth Factor 13.7433980.00003695Upregulated
TNNC1Troponin C1, slow skeletal and cardiac type3.6020370.00004852Upregulated
CYP2C8Cytochrome P450 family 2 subfamily C member 8-3.556710.00004895Downregulated
THBS1Thrombospondin 13.1700900.00005034Upregulated
VEGFAVascular endothelial growth Factor A4.2616450.00005391Upregulated
LUNAR1Leukemia-associated noncoding IGF1R activator RNA 13.2651150.00005733Downregulated
HOXD1Homeobox D13.8128930.00005999Upregulated
BMP2bone morphogenetic protein 23.1154850.00006297Upregulated
IQGAP2IQ motif containing GTPase activating protein 22.5404330.00006536Upregulated
ST3GAL6ST3 beta-galactoside alpha-2,3-sialyltransferase 62.8581000.00006870Upregulated
THSD7AThrombospondin type 1 domain containing 7A2.5810300.00006966Upregulated
F2RCoagulation factor II thrombin receptor2.8091480.00007121Upregulated
SLC9A1Solute carrier family 9 member A14.3309250.00007424Downregulated
ADORA2BAdenosine A2b receptor2.5823780.00008127Downregulated
FAM153AFamily with sequence similarity 153 member A3.7743750.00009200Upregulated
ITGB1Integrin subunit beta 13.7743280.00009284Downregulated
CDS1CDP-diacylglycerol synthase 12.6952870.00009577Upregulated
EGR2Early growth response 23.5802850.00010401Downregulated
PLA2R1Phospholipase A2 receptor 13.4851080.00010718Upregulated
GAS1Growth arrest specific 13.6590520.00010882Upregulated
TYRO3TYRO3 protein tyrosine kinase2.8540820.00011003Upregulated
LOC101929500Uncharacterized LOC1019295002.6649310.00011229Upregulated
F3Coagulation factor III, tissue factor3.0356910.00011752Upregulated
XPNPEP2X-prolyl aminopeptidase 23.4548280.00013038Downregulated
FUT6Fucosyltransferase 63.3572470.00013492Downregulated
LCN1Lipocalin 12.6540970.00014868Downregulated
C1orf21Chromosome 1 open reading frame 212.6558850.00015593Upregulated
LOC103344931Uncharacterized LOC1033449312.4238610.00015641Upregulated
FRYFRY microtubule binding protein2.9220640.00016127Upregulated
POU2F2POU class 2 homeobox 2-2.519720.00016162Downregulated
VEGFAVascular endothelial growth Factor A2.8601800.00016446Upregulated
CHRNECholinergic receptor nicotinic epsilon subunit2.9544350.00016654Downregulated
TUBB4ATubulin beta 4A class IVa3.9085270.00016713Downregulated
MGAT5Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase2.5686780.00017864Upregulated
PTPRDProtein tyrosine phosphatase receptor type D3.0522490.00018095Upregulated
HYAL1Hyaluronidase 1-2.2176400.00018409Downregulated
DPYSL3Dihydropyrimidinase like 33.7822040.00018554Upregulated
UGT2B17UDP glucuronosyltransferase family 2 member B172.6045040.00018633Downregulated
PAMPeptidylglycine alpha-amidating monooxygenase2.255750.00018848Upregulated
RFC4Replication Factor C subunit 43.0941090.00020080Downregulated
Table 4 Core active ingredients of the Astragalus-Coptis drug pair
Serial number
MOL ID
Ingredient
Degree
HQ4MOL0003713,9-di-O-methylnissolin66.0
HQ6MOL000354Isorhamnetin63.0
HQ9MOL000239Jaranol63.0
HQ10, HL12MOL000098Quercetin62.0
HQ13MOL0004221,7-Dihydroxy-3,9-dimethoxy pterocarpene62.0
HQ11MOL000438(3R)-3-(2-hydroxy-3,4-dimethoxyphenyl)chroman-7-ol58.0
HL11MOL000785Palmatine58.0
HL10MOL013352Obacunone57.0
HL9MOL008647Moupinamide56.0
Table 5 Analysis of topological parameters of key targets
Name
Degree centrality
Betweenness centrality
Closeness centrality
Degree
AKT11556135.220268480020.0025839793281653746
EGFR1272630.661657516480.0023923444976076544
TNF1556936.34372604360.0025706940874035943
SRC1293308.849276429640.0024038461538461543
JUN1171696.429731203890.0023201856148491843
CASP31162086.858122769040.0023364485981308443
MAPK31192232.219294461360.0023310023310023343
HSP90AA11243622.007914583810.0023584905660377341
STAT31231881.067284582540.0023419203747072640
ESR11021938.434414985110.0022421524663677138
Table 6 Kyoto Encyclopedia of Genes and Genomes enrichment results
ID
Term
Enrichment
P value
Count
hsa04933AGE-RAGE signaling pathway in diabetic complications10.21070042.05E-2231
hsa05417Lipid and atherosclerosis6.127952223.17E-2040
hsa04151PI3K-Akt signaling pathway4.559179143.19E-1949
hsa04066HIF-1 signaling pathway8.158890527.92E-1727
hsa04510Focal adhesion5.678921241.28E-1635
hsa04014Ras signaling pathway5.163968214.42E-1637
hsa04012ErbB signaling pathway8.912565803.47E-1523
hsa04664Fc epsilon RI signaling pathway10.17195014.44E-1521
hsa04931Insulin resistance7.624477597.90E-1525
hsa04068FoxO signaling pathway6.788695161.03E-1427
hsa04010MAPK signaling pathway4.253549623.49E-1439
hsa04062Chemokine signaling pathway5.318073127.06E-1431
hsa04926Relaxin signaling pathway6.383283565.15E-1325
hsa05418Fluid shear stress and atherosclerosis5.924054532.81E-1225
hsa04668TNF signaling pathway6.645334152.32E-1223
hsa04657IL-17 signaling pathway5.956825901.70E-0817
hsa04922Glucagon signaling pathway4.309611261.88E-0514
hsa04614Renin-angiotensin system10.02453054.72E-057
hsa04960Aldosterone-regulated sodium reabsorption7.121674201.01E-048
hsa04152AMPK signaling pathway4.899829571.15E-0718